Jane C. Edmond, MD, starts term as 2024 president of AAO
January 13th 2024According to an American Academy of Ophthalmology news release, Edmond’s priorities during her term include addressing physician and staff shortages and protecting patient safety at a time when nonphysicians are trying to expand their scope of practice into eye surgery.
AAO 2023: Intracanalicular dexamethasone insert using IRIS Registry
December 1st 2023Benjamin Y Xu, MD, spoke with the Ophthalmology Times team about the real-world safety analysis of patients treated with intracanalicular dexamethasone insert using IRIS Registry at this year's American Academy of Ophthalmology meeting.
AAO 2023: AVD-104 and the results of the phase II/III part 1 SIGLEC trial
November 26th 2023Mohammed Genead, MD, CEO of Aviceda spoke with the Ophthalmology Times team about the company's Phase II/III SIGLEC trial part 1 results, which were shared at this year's American Academy of Ophthalmology meeting.
AAO 2023: Post-hoc analysis of the YOSEMITE and RHINE clinical trials
November 24th 2023Marco A. Zarbin, MD, spoke with the Ophthalmology Times team about conducting a post-hoc analysis of the YOSEMITE and RHINE clinical trials and presenting the results at this year's American Academy of Ophthalmology meeting.
AAO 2023: ModMed's new initiative simplifying the charting process
November 23rd 2023Michael Rivers, MD, Senior Director of Ophthalmology at ModMed spoke with Modern Retina about their new single-screen initiative and the benefits it could have for saving time and simplifying communication within practices.
AAO 2023: Retinal visualization and patients who've had small aperture IOL implantation
November 21st 2023Mark Blecher, MD, spoke with the Ophthalmology Times team about his poster addressing retinal visualization and patients who've had small aperture IOL implantation at this year's American Academy of Ophthalmology meeting.
AAO 2023: ViaLase announces completion of VIA-002 trial
November 14th 2023Rick Lewis, MD, Chief Medical Officer for ViaLase met with Ophthalmology Times to discuss completion of their important pivotal trial called VIA-002, which is a randomized prospective trial of the use of the ViaLase Laser versus SLT in adult patients with primary open angle glaucoma at the American Academy of Ophthalmology.
AAO 2023: Latest diagnostic and therapeutic advancements in ocular infections
November 13th 2023Penny Asbell, MD, FACS, spoke with Ophthalmology Times about her poster on results from the ARMOR Study and latest diagnostic and therapeutic advancements in ocular infections at this year's American Academy of Ophthalmology meeting.
AA0 2023: Study on internationally collected cohorts and the consistency of outcomes
November 11th 2023Clara Chan, MD, FRSCS, FACS, DABO, from the University of Toronto spoke with Ophthalmology Times about their study on the consistency of outcomes across 3 different cohorts of patients that were internationally collected at this year's American Academy of Ophthalmology meeting.
AAO 2023: TECNIS Symfony lens or TECNIS Symfony OptiBlue lens?
November 10th 2023Daniel Chang, MD, spoke with Ophthalmology Times about his poster "Clinical performance of a diffractive, extended depth-of-focus IOL, with violet light filtering and high-resolution lathing" at this year's American Academy of Ophthalmology meeting.